title: [Therapeutic effect of intraperitoneal administration of CDDP and OK-432 in peritonitis carcinomatosa cases in postoperative gastric carcinoma].
authors.affiliation: Dept. of Surgery, Osaka Hospital of West Japan, Railway Company.
authors.forename: T
authors.initials: T
authors.lastname: Tanaka
authors.forename: H
authors.initials: H
authors.lastname: Itoi
authors.forename: S
authors.initials: S
authors.lastname: Matsui
authors.forename: A
authors.initials: A
authors.lastname: Nakae
authors.forename: K
authors.initials: K
authors.lastname: Nagashima
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001202:Ascitic Fluid / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D016131:Lymphocyte Subsets; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D010844:Picibanil / Q000008:administration & dosage; D011184:Postoperative Period; D011379:Prognosis; D013274:Stomach Neoplasms / Q000150:complications* / Q000601:surgery
chemical_list: D010844:Picibanil; D002945:Cisplatin